Daniela Reghellin

1.2k total citations
16 papers, 890 citations indexed

About

Daniela Reghellin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Daniela Reghellin has authored 16 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Daniela Reghellin's work include Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (5 papers) and Tuberous Sclerosis Complex Research (4 papers). Daniela Reghellin is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (5 papers) and Tuberous Sclerosis Complex Research (4 papers). Daniela Reghellin collaborates with scholars based in Italy, United Kingdom and Switzerland. Daniela Reghellin's co-authors include Franco Bonetti, Guido Martignoni, Maurizio Pea, Giuseppe Zamboni, Marco Chilosi, Erminia Manfrin, Andrea Remo, Stefano Gobbo, Matteo Brunelli and Venerino Poletti and has published in prestigious journals such as Cancer, Breast Cancer Research and Treatment and American Journal of Clinical Pathology.

In The Last Decade

Daniela Reghellin

15 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Reghellin Italy 14 489 469 379 186 121 16 890
Aldo Mombello Italy 14 222 0.5× 239 0.5× 273 0.7× 198 1.1× 154 1.3× 30 718
Natalie Vena United States 11 162 0.3× 414 0.9× 374 1.0× 393 2.1× 107 0.9× 16 1.0k
Anna Caliò Italy 22 160 0.3× 830 1.8× 599 1.6× 560 3.0× 75 0.6× 74 1.4k
Diego Segala Italy 15 199 0.4× 615 1.3× 214 0.6× 492 2.6× 20 0.2× 23 825
Qiu Rao China 23 225 0.5× 869 1.9× 378 1.0× 857 4.6× 174 1.4× 109 1.5k
G.M. Mariuzzi Italy 12 130 0.3× 131 0.3× 169 0.4× 82 0.4× 64 0.5× 28 453
Andrea Sendelhofert Germany 13 105 0.2× 112 0.2× 573 1.5× 245 1.3× 67 0.6× 21 840
Linda N. Dao United States 10 145 0.3× 125 0.3× 251 0.7× 208 1.1× 245 2.0× 29 723
A. J. M. Balm Netherlands 11 69 0.1× 175 0.4× 416 1.1× 279 1.5× 60 0.5× 22 720
Chisato Ohe Japan 19 66 0.1× 727 1.6× 213 0.6× 509 2.7× 53 0.4× 92 1.1k

Countries citing papers authored by Daniela Reghellin

Since Specialization
Citations

This map shows the geographic impact of Daniela Reghellin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Reghellin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Reghellin more than expected).

Fields of papers citing papers by Daniela Reghellin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Reghellin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Reghellin. The network helps show where Daniela Reghellin may publish in the future.

Co-authorship network of co-authors of Daniela Reghellin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Reghellin. A scholar is included among the top collaborators of Daniela Reghellin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Reghellin. Daniela Reghellin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Calvetti, Lorenzo, et al.. (2023). EP13.03-02 Improved Long-Term Survival and Less Chemotherapy in Extended-SCLC Patients: A Real-World Study in the Immunotherapy Era. Journal of Thoracic Oncology. 18(11). S690–S690.
2.
Martignoni, Guido, Maurizio Pea, Daniela Reghellin, et al.. (2010). Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors.. Archives of Pathology & Laboratory Medicine. 134(1). 33–40. 40 indexed citations
3.
Reghellin, Daniela, Venerino Poletti, Alberto Cavazza, et al.. (2010). Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis.. PubMed. 27(1). 57–63. 18 indexed citations
4.
Martignoni, Guido, Maurizio Pea, Daniela Reghellin, et al.. (2010). Molecular Pathology of Lymphangioleiomyomatosis and Other Perivascular Epithelioid Cell Tumors. Archives of Pathology & Laboratory Medicine. 134(1). 33–40. 36 indexed citations
5.
Brunelli, Matteo, Erminia Manfrin, Keith Miller, et al.. (2009). Her‐2/neu evaluation in Sister Mary Joseph’s nodule from breast carcinoma: a case report and review of the literature. Journal of Cutaneous Pathology. 36(6). 702–705. 5 indexed citations
6.
Brunelli, Matteo, Erminia Manfrin, Guido Martignoni, et al.. (2009). Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification. American Journal of Clinical Pathology. 131(5). 678–682. 87 indexed citations
7.
Manfrin, Erminia, et al.. (2009). Cancer size, histotype, and cellular grade may limit the success of fine‐needle aspiration cytology for screen‐detected breast carcinoma. Cancer Cytopathology. 117(6). 491–499. 21 indexed citations
8.
Manfrin, Erminia, et al.. (2008). Is there still a role for fine-needle aspiration cytology in breast cancer screening?. Cancer. 114(2). 74–82. 23 indexed citations
9.
Brunelli, Matteo, Erminia Manfrin, Guido Martignoni, et al.. (2008). HER-2/neu Assessment in Breast Cancer Using the Original FDA and New ASCO/CAP Guideline Recommendations. American Journal of Clinical Pathology. 129(6). 907–911. 42 indexed citations
10.
Manfrin, Erminia, Andrea Remo, Daniela Reghellin, et al.. (2008). Benign breast lesions at risk of developing cancer—A challenging problem in breast cancer screening programs. Cancer. 115(3). 499–507. 14 indexed citations
11.
Martignoni, Guido, Maurizio Pea, Daniela Reghellin, Giuseppe Zamboni, & Franco Bonetti. (2007). PEComas: the past, the present and the future. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 452(2). 119–132. 388 indexed citations
12.
Manfrin, Erminia, et al.. (2007). Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases. Breast Cancer Research and Treatment. 107(3). 371–377. 33 indexed citations
13.
Chilosi, Marco, Alberto Zamò, Claudio Doglioni, et al.. (2006). Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respiratory Research. 7(1). 95–95. 84 indexed citations
14.
Martignoni, Guido, Maurizio Pea, Daniela Reghellin, Giuseppe Zamboni, & Franco Bonetti. (2006). Perivascular Epithelioid Cell Tumor (PEComa) in the Genitourinary Tract. Advances in Anatomic Pathology. 14(1). 36–41. 48 indexed citations
15.
Davì, Maria Vittoria, Lisa Bodei, Giuseppe Francia, et al.. (2006). Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid). Journal of Endocrinological Investigation. 29(6). 563–567. 24 indexed citations
16.
Zamò, Alberto, Venerino Poletti, Daniela Reghellin, et al.. (2005). HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis.. PubMed. 22(2). 123–8. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026